McLaren’s report: Doping cover-up in Russia was unprecedentedSport December 09, 14:23
Nearly 11,000 people leave Aleppo’s areas controlled by militants over past 24 hoursWorld December 09, 14:09
Lavrov sees good chance of reaching deal with US on militants withdrawal from AleppoRussian Politics & Diplomacy December 09, 14:04
South Korean president transfers power to prime ministerWorld December 09, 13:56
Russian top diplomat praises OSCE contribution to settlement in UkraineRussian Politics & Diplomacy December 09, 13:44
Peskov says top-notch lawyers hammered out Rosneft’s privatization dealBusiness & Economy December 09, 13:37
Press review: McLaren’s second round of anti-doping crusade and trilateral gas talksPress Review December 09, 13:00
Pole vault star Isinbayeva withdraws her candidacy for post of Russian athletics chiefSport December 09, 12:55
Kremlin warns obtaining of US MANPADS by Syrian militants dangerous for Russian Air ForceRussian Politics & Diplomacy December 09, 12:12
LONDON, June 14. /TASS/. Russian tennis star Maria Sharapova said she would file an appeal with the Court of Arbitration for Sports (CAS) against her two-year suspension, imposed last week by the International Tennis Federation’s (ITF) Tribunal over anti-doping violations, Britain’s web portal Sky News reported on Tuesday.
In early March, Sharapova announced that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.